Citigroup (NYSE:C) stock is getting fresh Wall Street validation this week, with three major firms raising their price targets following a blowout first quarter. Goldman Sachs, Truist, and Wells Fargo all moved their targets higher after Citi reported Q1 2026 EPS of $3.06 and revenue of $24.6 billion, up 14% year-over-year. The question for long-term investors: is the transformation story finally hitting its stride?
The numbers make a compelling case. Citigroup’s net income surged 42% year-over-year to $5.8 billion, and the Markets segment crossed $7 billion in quarterly revenue for the first time in a decade. For a bank that spent years in restructuring mode, that’s a meaningful signal the hard work is paying off.
| Ticker | Company | Firm | Action | Old Rating | New Rating | Old Target | New Target |
|---|---|---|---|---|---|---|---|
| C | Citigroup | Goldman Sachs | Price Target Raised | Buy | Buy | $137 | $151 |
| C | Citigroup | Truist | Price Target Raised | Buy | Buy | $133 | $139 |
| C | Citigroup | Wells Fargo | Price Target Raised | Overweight | Overweight | $150 | $160 |
The Analyst’s Case
Goldman Sachs analyst Richard Ramsden raised his price target on Citigroup to $151 from $137, maintaining a Buy rating, citing strong quarterly results that underscore continued momentum behind Citi’s core franchises and ongoing transformation success. That’s a vote of confidence not just in one quarter, but in the durability of the business model.
Truist analyst John McDonald lifted his Citigroup stock price target to $139 from $133, keeping a Buy rating, pointing to better revenue growth and a higher level of share buybacks, partially offset by higher provision expense and non-controlling interest attribution related to the Banamex stake sales. Truist sees the positives clearly but isn’t ignoring the moving parts.
Wells Fargo raised its target to $160 from $150, maintaining an Overweight rating, noting that Citi showed strong top-line double-digit growth even amid its restructuring, which appears unique not only among banks but also by companies generally. That’s notable in a sector where most peers are reporting more modest gains.
Why the Move Matters Now
Citigroup’s ROTCE hit 13% in Q1, well above the full-year guidance of 10% to 11%, giving analysts room to argue the bank could beat its own targets. The efficiency ratio improved 400 basis points year-over-year to 58%, a sign that cost discipline is translating into real margin expansion.
Citi repurchased $6.3 billion in shares during Q1 alone, with total capital returned to shareholders reaching $7.4 billion. That level of buyback activity is hard to ignore for income-focused investors watching capital allocation closely.
What It Means for Your Portfolio
Citigroup stock carries a trailing P/E ratio of 16x and a forward P/E ratio of 12x, which looks reasonable given the earnings trajectory. The analyst consensus target sits at $133, with 19 Buy ratings and no Sell ratings on record, reflecting broad institutional confidence.
The bull case rests on Citigroup’s transformation completion, capital return momentum, and a business mix firing across all five segments. The bear case centers on the $597 million ACL reserve build and a 42% year-over-year rise in corporate non-accrual loans, both worth watching as the macro environment evolves. With an Investor Day scheduled for May, the next catalyst for Citigroup is already on the calendar.
Top Gaining Stocks
Top Losing Stocks